Ultragenyx Pharmaceutical
RARE
#3219
Rank
A$5.36 B
Marketcap
$57.11
Share price
2.84%
Change (1 day)
-16.13%
Change (1 year)

Earnings for Ultragenyx Pharmaceutical (RARE)

Earnings in 2024 (TTM): -A$0.77 Billion

According to Ultragenyx Pharmaceutical's latest financial reports the company's current earnings are A$0.56 Billion. , an increase over its 2023 earnings that were of -A$0.85 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ultragenyx Pharmaceutical from 2013 to 2024

Annual earnings

Year Earnings Change
2024 -A$0.79 Billion-6.99%
2023 -A$0.85 Billion-17.65%
2022 -A$1.03 Billion55.52%
2021 -A$0.66 Billion178.53%
2020 -A$0.24 Billion-59.64%
2019 -A$0.59 Billion1.46%
2018 -A$0.58 Billion12.9%
2017 -A$0.52 Billion32.63%
2016 -A$0.39 Billion67.87%
2015 -A$0.23 Billion160.2%
2014 -A$88.35 Million66.64%
2013 -A$53.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$0.84 B-207.38%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$44.75 Million-94.30%๐Ÿ‡บ๐Ÿ‡ธ USA
A$11.67 M-101.49%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.32 Billion-60.28%๐Ÿ‡บ๐Ÿ‡ธ USA